Case report: A case of yellow fever vaccine-associated viscerotropic disease in Ecuador

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 4, 2010, Pages 740-742

  Douce, Richard W ^a   Freire, Diana ^a   Tello, Betzabe ^a   Vásquez, Gavino A ^a  

^a HOSPITAL VOZANDES   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE; LYSINE; PARACETAMOL; YELLOW FEVER VACCINE;

ABDOMINAL PAIN; AGED; ANXIETY DISORDER; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; DYSPNEA; ECUADOR; FEVER; HEADACHE; HUMAN; JAUNDICE; LEUKOPENIA; MALE; NAUSEA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNDROME DELINEATION; THROMBOCYTOPENIA; VACCINATION; VISCEROTROPIC SYNDROME; VOMITING; YELLOW FEVER; FATALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ECUADOR; FATAL OUTCOME; HUMANS; MALE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YELLOW FEVER VACCINE;

EID: 77950935075     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0570     Document Type: Article

References (18)

1. Pan American Health Organization, 2005. Control of Yellow Fever: Field Guide. Washington, DC: Pan American Health Organization.
2. Pan American Health Organization, 2008. Outbreak of yellow fever in Paraguay. PAHO Epidemiol Bull 27: 1-7.
3. Pan American Health Organization, 2008. Final Statement by the Pan American Health Organization/World Health Organization (PAHO/WHO) on Investigation of Serious Adverse Events in Peru following Receipt of Yellow Fever Vaccine Produced by Bio-Manguinhos, Brazil. Posted March 21, 2008 [cited 2009 Apr 23]. Available at: http://www paho org/English/AD/DPC/CD/eid-eer-2008- 03-27 htm.
4. Barnett ED, 2007. Yellow fever: epidemiology and prevention. Clin Infect Dis 44: 850-856.
5. Martin M, Tsai TF, Cropp B, Chang GJ, Holmes DA, Tseng J, Shieh W, Zaki SR, Al-Sanouri I, Cutrona AF, Ray G, Weld LH, Cetron MS, 2001. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 358: 98-104.
6. 2002. Adverse events associated with 17D-derived yellow fever vaccination - United States, 2001-2002. MMWR Morb Mortal Wkly Rep 51: 989-993.
7. Engel AR, Vasconcelos PF, McArthur MA, Barrett AD, 2006. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 24: 2803-2809.
8. Centers for Disease Control and Prevention, 2002. Adverse events associated with 17D-derived yellow fever vaccination - United States, 2001-2002. MMWR Morb Mortal Wkly Rep 51: 989-993.
9. Bae HG, Domingo C, Tenorio A, de Ory F, Munoz J, Weber P, Teuwen DE, Niedrig M, 2008. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis 197: 1577-1584.
10. Munoz J, Vilella A, Domingo C, Nicolas JM, de Ory F, Corachan M, Tenorio J, Gascon J, 2008. Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med 15: 202-205.
11. Engel AR, Vasconcelos PF, McArthur MA, Barrett AD, 2006. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 24: 2803-2809.
12. Martin M, Weld LH, Tsai TF, Mootrey GT, Chen RT, Niu M, Cetron MS; GeoSentinel Yellow Fever Working Group, 2001. Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis 7: 945-951.
13. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.
14. Whittembury A, Ramirez G, Hernandez H, Ropero AM, Waterman S, Ticona M, Brinton M, Uchuya J, Gershman M, Toledo W, Staples E, Campos C, Martinez M, Chang GJ, Cabezas C, Lanciotti R, Zaki S, Montgomery JM, Monath T, Hayes E; Ministerio de Salud, Lima, Peru, 2009. Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27: 5974-5981.
15. Monath TP, Cetron MS, 2002. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 1369-1378.
16. Wilder-Smith A, Hill DR, Freedman DO, 2008. The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice. Am J Trop Med Hyg 78: 359-360.
17. Monath TP, 2007. Dengue and yellow fever - challenges for the development and use of vaccines. N Engl J Med 357: 2222-2225.
18. Kramer LD, Li J, Shi PY, 2007. West Nile virus. Lancet Neurol 6: 171-181.